Vir Biotechnology, Inc.
VIR · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1,000 | $1,349 | $3,356 | $5,438 |
| - Cash | $223 | $242 | $849 | $348 |
| + Debt | $98 | $125 | $128 | $134 |
| Enterprise Value | $875 | $1,232 | $2,636 | $5,224 |
| Revenue | $74 | $86 | $1,616 | $1,095 |
| % Growth | -13.9% | -94.7% | 47.5% | – |
| Gross Profit | -$404 | -$487 | $995 | $582 |
| % Margin | -545% | -564.7% | 61.6% | 53.1% |
| EBITDA | -$509 | -$642 | $840 | $427 |
| % Margin | -685.8% | -744.5% | 52% | 38.9% |
| Net Income | -$522 | -$615 | $516 | $529 |
| % Margin | -703.4% | -713.7% | 31.9% | 48.3% |
| EPS Diluted | -3.83 | -4.59 | 3.83 | 3.96 |
| % Growth | 16.6% | -219.8% | -3.3% | – |
| Operating Cash Flow | -$446 | -$779 | $1,663 | -$48 |
| Capital Expenditures | -$7 | -$22 | -$68 | -$22 |
| Free Cash Flow | -$454 | -$800 | $1,595 | -$69 |